Carsten Thiel And Biotechnology’s Golden Age

 

Humanity is on the cusp of a golden age of biotechnology, and it is entirely possible that we will all soon be leading much longer lives virtually free of disease. Just as the world has been through the space age and the computer age, soon we will be living in the biotechnology age.

The speed of advancement in biotechnology is now exponential; a tipping point has been reached, and as biotechnology expert Carsten Thiel and others explains, there are three main reasons for this.

Progress in Technology

Sequencing the human genome has gotten dramatically cheaper since the process was introduced in the 1990’s, and this is because of the increasing speed and storage capacities of computers. Today, experts like Carsten Thiel can use the human genome itself in their research; whereas, in the past, it was necessary to look at mice.

Better comprehension of human biology

Improved technology leads to improved understanding. Carsten Thiel and other biotechnology experts now see biology more in terms of engineering than ever before.

Carsten Thiel has a Ph.D and was the CEO of Abeona Therapeutics Inc. This is a biopharmaceutical company for clinical-stages that mainly develops gene and cell therapies for genetic diseases that are rare and life-threatening. It is a company that is a major part of the golden age of biotechnology that Carsten Thiel is very much a part of.

Just as in the 1990’s when the target biology revolution made it possible to develop drugs to treat AIDS and other diseases, machine learning, automation and the quantification of biology will likely lead to breakthroughs in medicine in the near future. Go To This Page for additional information.

More tools

Gene therapies, nucleic acids and non-particle delivery systems are just some of the new modalities researchers and doctors are now using to research disease. In short, the future is bright for medicine.

 

See also: https://in.reuters.com/article/brief-abeona-therapeutics-appoints-carst/brief-abeona-therapeutics-appoints-carsten-thiel-ph-d-as-chief-executive-officer-idINASC09UFV

 

Leave a Reply

Your email address will not be published. Required fields are marked *